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Purpose: Melatonin, the most potent scavenger of toxic free
radicals, has been found to be effective in protecting against
pathological states due to the release of reactive oxygen
species. This study was performed to establish the effect of
high dose melatonin on protection against ischemia-
reperfusion (I/R) injury in rat hearts. Materials and Methods:
Forty male Sprague-Dawley rats were used in this study. They
were separated into four groups of ten rats each. A left
coronary artery occlusion was induced in the rats by ligating
the artery for 20 minutes and then releasing the ligation
(reperfusion) afterwards. The control group was Group A.
Group B was subjected to myocardial ischemia-reperfusion
without any treatment, while Group C underwent myocardial
ischemia-reperfusion with a melatonin treatment before the
ischemia. Group D was subjected to myocardial ischemia-
reperfusion with a melatonin treatment before the reperfusion.
After 20 minutes of reperfusion, blood samples were obtained
from each group for biochemical studies, and the animals were
sacrificed for histological and, immunohistochemical
examinations of the myocardial tissue. Results: We found that
the cardiac troponin T(cTn-T) levels were significantly
increased in Group B when all groups were compared. In the
Group C rats treated with melatonin, the cTn-T values were
significantly lower than those in Groups B and D. In addition,
malondialdehyde (MDA) and antioxidant enzymes including,
superoxide dismutase (SOD) and myeloperoxidase (MPO)
were lower than those in Group B in the melatonin treated
groups. The differences were statistically significant (p < 0.05).
Histopathologic and immunohistopathologic studies also
supported the effectiveness of melatonin. Conclusion: Our
study suggests that high dose melatonin, appears to offer
protection against cardiac ischemia-reperfusion injuries in rats
by scavenging the free radicals and could have a potential
clinical use in the management of myocardial ischemia.
Key Words: Melatonin, myocardial ischemia-reperfusion,
antioxidant, Fas and Bcl-2 expression
INTRODUCTION
Cell injury occurring after ischemia-reperfusion
(I/R) in the heart is attributed to necrosis caused
by calcium overload, acidosis, and oxidative
stress.
1 After I/R, myocardial cells die by necrosis
and/or apoptosis. Apoptosis is a process for
disposing of injured or redundant cells through
self-destruction.
2 Free radicals and antioxidants
play an important role in cellular damage that can
cause atherosclerosis and myocardial infarction.
Both neutrophils and free radicals, such as super-
oxide anions, hydroxyl radicals and hydrogen
peroxide, can cause oxidative damage to cell
lipids, proteins, and nucleic acids.
3
Melatonin (N-acetyl-5-methoxytryptamine) is
secreted by the pineal gland, and has been
confirmed to be potent scavenger of hydroxyl and
peroxyl radicals.
3,4 Many researchers have con-
sidered the antioxidant role of melatonin and it is
ability to trap cellular free radicals.
5 In addition,
melatonin has also been shown to act as an
immune system modulator.
6 Although there is a
large amount of consistent data available that
shows the potential protective effect of melatonin
in cells, a consensus still exists that reactive oxygen
species play an important role in the pathogenesis
of cardiac reperfusion injury.
7 Several previous
studies have examined melatonin and its effect on
cell death following ischemia-reperfusion. What
differentiates our study is the combination of
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histological parameters, immunohistopathologic
studies and biochemical parameters that support
the hypothesis that high-dose melatonin provides
effective protection following I/R.
MATERIALS AND METHODS
This study was performed in the Hakan
Çetinsaya Clinical and Experimental-Research
Center at Erciyes University. The Ethics Com-
mittee approved this study. All animals involved
received humane care in compliance with the
European Convention on Animal Care.
Animals
Male Sprague-Dawley rats (n = 40) weighing
310 to 340 g (average 321 g) were used in this
study. The rats were anesthetized with ketamine
hydrochloride (20 mg/kg), intraperitoneally (i.p.),
and heparin (500 IU/kg, i.p) was also admini-
stered.
A left thoracotomy was performed, and the
pericardium was incised. The left coronary artery
was surgically occluded through ligation with a
suture (monoflamant polypropylene, size 6.0) and
than followed with a coronary reperfusion
through the release of the tie.
Rats were separated in to four groups
Group A (n = 10) was the control group and no
procedures were carried out.
Group B (n = 10) was subjected to cardiac is-
chemia (20 minutes) - reperfusion (20 minutes)
without any treatment.
Group C (n = 10) was treated with melatonin
(50 mg/kg i.p, Sigma, M-5250, St. Louis, MO,
USA) 30 minutes before ischemia (20 minutes) -
reperfusion (20 minutes).
Group D (n = 10) uderwent left coronary artery
occlusion (ischemia time of 20 minutes) and then
melatonin (50 mg/kg i.p.) was administered just
before reperfusion.
Rats that developed ventricular fibrillation or
cardiac arrest during I/R were excluded from the
study, so only the 40 rats that did not have any
complications were used. For biochemical testing
blood samples were taken from all rats via the
atrium using a 22 G intravenous cannula
(Polyflon) after 20 minutes reperfusion. Hepar-
inized blood obtained from the rats was cen-
trifuged at 2,000 rpm for 15 minutes at 4°C. After
separating the plasma, the samples were stored at
-20°C until analysis. Tissue samples were taken
from the left ventricle and bathed in a 10%
formalin solution for pathologic study. The tissue
samples were stained with Hematoxylin and
Eosin (H & E) and were evaluated by light micro-
scopy.
Immunohistochemical analysis of Fas and Bcl-2
expression
Over the last few years, compelling evidence
has established an important physiologic role for
apoptotic cell death in maintaining optimal cell
numbers in multicellular organisms. Proteins such
as Bcl-2 or Fas and its ligand, have been shown
to regulate this process.
Representative sections of the heart tissue were
fixed in 10% neutral buffered formalin for 24
hours. After standard histological processing the
sections were embedded in paraffin, then 5- m μ
paraffin sections were deparaffinized with three
rinses of xylene, and than followed by rehyded
with ethanol. To unmask any antigenic deter-
minants, slides were pretreated in a microwave
for 10 minutes in a 0.01 M. citrate buffer, treated
for 30 minutes in 0.5% H2O2, then washed with
PBS (phosphate buffered saline: SIGMA #1000-3).
Next the sections were incubated with the
primary antibodies (1 : 10 dilution overnight for
Fas, 1 : 50 dilution overnight for Bcl-2). Both
mouse monoclonal antibodies against Fas, and
mouse monoclonal antibodies against Bcl-2 (both
from DAKO Corporation, Carpenteria, CA, USA)
were used in this study. The immunohistochemical
staining was performed using the streptoavidin-
biotin kit (DAKO Corporation, Carpenteria, CA,
USA) by the avidin-biotin-peroxidase method,
according to the manufacturer's instructions. The
peroxidase reaction was developed with 3,3'-dia-
minobenzidine, and the slides were counterstained
with hematoxylin. Formalin-fixed, paraffin-
embedded sections of the colon were used as
positive controls for Fas, and tonsil sections were
used as controls in Bcl-2 staining.The Effect of High Dose Melatonin on Cardiac Ischemia-reperfusion Injury
Yonsei Med J Vol. 49, No. 5, 2008
The intensity of immunostaining was evaluated
by repeated staining of the same specimens, and
an observer who had no knowledge of the
experimental group examined the staining. The
immunostaining was graded as "0" for no immu-
nostaining or as, "1" if immunostaining was
definitely detectable.
Determination of myeloperoxidase (MPO) activity
The assay mixture was composed of a 0.3 mL
100 mM phosphate buffer (pH 6.0; 0.3 mL 10 mM
H2O2, 0.5 mL 20 mM o-dionisidine (freshly pre-
pared) in deionized water; and 10 mL PMNL
homogenate in a final volume of 3.0 mL. The
absorbance at 460 nm was followed for 10 minutes.
All measurements were carried out in duplicate.
One unit of MPO was defined as that which
degrade 1 mmol H2O2/min at 25°C; specific
activity was given as U/mg of protein. A molar
extinction coefficient of 11,300 for oxidized
o-dianisidine was used for the calculation.
Determination of malondialdehyde (MDA) activity
The determination of MDA, was measured
using the spectrophotometrical method defined
by Ohkawa et al. in 1979. MDA couples to thiobar-
bituric acid to form a pink chromogen compound,
which has a maximum absorbance at 540 nm in
wavelength. Plasma MDA levels were expressed
as micromoles per liter ( mol MDA/liter). μ
Determination of superoxide dismutase (SOD)
activity
The enzymatic activity of SOD was measured
according to the inhibition of nitroblue tetrazo-
lium (NBT) reduction with xanthine-xanthine ox-
idase used as a superoxide generator. One unit of
SOD activity was defined as the amount of protein
that inhibited the rate of NBT reduction by 50%.
Enzyme activity was expressed as U/mg protein.
Statistical analysis
A Kruskal-Wallis non-parametric variance an-
alysis was performed to test the significance of the
p value obtained between groups. All groups were
analyzed with one another using the Mann-
Whitney U Test. A p value lower than 0.05 was
considered significant.
RESULTS
Troponin
In Group A, cTn-T values were significantly
lower in comparison with all other groups. The
cTn-T values in Group B were significantly
higher compared with all other groups. In
Group C, where melatonin treatment was used
before ischemia, cTn-T values were significantly
lower than Groups B and D, which signified the
efficacy of pre-ischemia treatment (Table 1).
MDA
The values of MDA in Group A, were signifi-
cantly lower compared with all groups. In both
Groups C and D where melatonin treatments
were used a significantly lower level of MDAs
was seen than that of Group B (Table 1).
MPO
The values of MPO in both Groups C and D,
which received melatonin treatments, were
significantly lower than in Group B (Table 1).
SOD
The values of SOD in Groups C and D, where
melatonin treatments, were used showed signifi-
cantly lower levels than Group B. There were no
significant differences between Groups C and A
for these levels (Table 1).
Immunohistochemical studies showed that
apoptotic activity in Group B was more intensive
than in the other groups (Fig. 1). Melatonin
treatment was associated with diminishing Fas
expression in ischemic-reperfused hearts in rats.
Bcl-2 expression was significantly higher in
Groups C and D (Figs 1 and 2).
The light microscopic study established the
existence of several indications of I/R injuries
such as edema in cardiac myofibrilles, increasedHakan Ceyran, et al.
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vascularity and increased inflammatory infil-
tration in Group B (Fig. 3). These findings were
minimal in the melatonin treated groups (Fig. 4).
DISCUSSION
It is well known that after myocardial ischemia,
free radicals, cytokines and antioxidants play a
major role in myocardial damage. Early reperfu-
sion of the ischemia can save the myocardium
before it becomes irreversibly injured. A delay in
reperfusion often results in injury to the myo-
cardial cells, which has been termed reperfusion
injury.
8,9 Oxygen-derived free radicals can cause
damage to various biological targets, such as
proteins, DNA, and lipids, and can also inflict
severe membrane damage with consequent cell
derangement or death.
10 SOD is a metalloenzyme
that catalyzes the dismutation of O2- into O2 and
H2O2, and affords protection against free radical
damage. It can also be associated with increased
oxidative stress.
3,11 Other important antioxidative
enzymes such as MPO and MDA also can result
in an increase in ischemia-reperfusion injuries.
12
Troponin T is one of the regulatory proteins of the
troponin complex, and cardiac troponin is one of
the isoforms of this complex. Even minor myo-
cardial damage can be detected using cardiac
troponin T levels. The importance of cTn-T is its
reilablity in identifying perioperative MI and in
the assessment of reperfusion therapy of an infarct
zone after MI.
13 In our study, the levels of cTn-T,
SOD, MDA, and MPO were significantly high
only in the non-treatment I/R group.
Fig. 2. Strong immunoreactivity with Bcl-2 in myofibrilles
in Group C (IHK × 200).
Fig. 3. Severe edema among myofibrilles in non-treated
melatonin Group B (H & E × 200).
Fig. 4. Minimal edema among myofibrilles in treated
melatonin Group C (H & E × 100).
Fig. 1. Melatonin treatment was associated with decrease
Fas expression while Bcl-2 expression were significantly
higher in ischemic-reperfused hearts in rats Groups C and
D.The Effect of High Dose Melatonin on Cardiac Ischemia-reperfusion Injury
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Cell death that occurs after I/R in the heart is
caused by energy depletion, acidosis, and oxidative
stress. Apoptosis occurs during I/R, and it is a
significant contributor to myocardial cell death.
Death receptors are cell surface receptors that
transmit apoptosis signals initiated by specific
ligands. The best characterization of the death
receptors is Fas. The Bcl-2 proteins are a family of
proteins involved in the response to apoptosis.
Some of these proteins (such as Bcl-2 and Bcl-XL)
are anti-apoptotic. The sensitivity of cells to
apoptotic stimuli can depend on the balance of
pro- and anti-apoptotic Bcl-2 proteins. The pro-
apoptotic Bcl-2 proteins are often found in the
cytosol, where they act as sensors of cellular
damage or stress.
2,8,14 In our study, apoptotic
activity was intensive in the non-treated I/R group.
Despite the discovery of melatonin more than
40 years ago, it was not recognized as an
antioxidant and a free radical scavenger until the
last ten years. Several investigators have shown
that melatonin is a derivative of the amino-acid
tryptophan, and is produced in the pineal gland.
Melatonin is a free radical scavenger that has the
ability to neutralize the toxicity of the hydroxyl
radical, the singlet oxygen, and possibly the
peroxyl radical and the superoxide anion.
15 Ianas
and colleagues were the first to investigate
melatonin as an antioxidant.
16 Later, Tan et al.
demonstrated that melatonin detoxifies the
hydroxyl radical.
4 Sainz et al. were the first to find
that both naturally-occurring and induced-
apoptosis is slowed down by melatonin.
17
As an antioxidant, melatonin is effective in
protecting DNA, membrane lipids and, presumably,
cytosolic proteins from oxidative damage. In
addition to its direct free radical scavenging and
membrane stabilization, melatonin has been
reported to alter the activities of enzymes that
improve the total antioxidative defense capacity of
the organism (including SOD, and nitric oxide
synthase).
18
The effect of melatonin on myocardial reper-
fusion injury has only been studied in recent
years. These studies have shown the effect of
melatonin on the incidence of myocardial reperfu-
sion arrhythmias, stunning, and the limitation of
infarct size.
3,19 The effect of melatonin on ischemia-
reperfusion-induced arrhythmias in the isolated
rat heart model has been reported, and it has been
found that melatonin is a potent agent in pro-
tecting against ischemia-reperfusion injury. This is
due to the hydroxyl radical scavenging effect of
melatonin and also due to the reduction of the
extent of lipid peroxidation.
3 In reviewing studies
that investigated the effects of antioxidants on the
limitation of infarct size, Bolli found that
approximately half of the 40 studies published
between 1984 - 1989 reported a reduction in infarct
size, while the other half did not find any effect.
The only consistent findings were that the
antioxidant had to be present during the entire
reperfusion period in order to produce positive
results.
20 The ability of melatonin to act as a
peroxyl radical scavenger was compared with that
of glutathione and Vitamins E, and C. Melatonin's
scavenging ability was about two times higher
than that of Vitamins E, and C and almost three
times higher than that of glutathione.
21
The protective effect of melatonin against
oxidative stress during reperfusion of the liver,
lungs, intestines and brain after induced ischemia
Table 1. Biochemical Parameters in Group A, B, C, and D
Groups A (n = 10) B (n = 10) C (n = 10) D (n = 10) p value
cTn-T 0.64 ± 0.22* 17.36 ± 2.20 2.05 ± 0.93 6.61 ± 1.29 < 0.05
MDA 0.81 ± 0.16* 1.92 ± 0.07 1.42 ± 0.06 1.40 ± 0.06 < 0.05
MPO 61.79 ± 4.73 166.05 ± 14.14 74.11 ± 2.20 83.52 ± 9.35 < 0.05
SOD 0.47 ± 0.04 0.85 ± 0.09 0.57 ± 0.02 0.58 ± 0.01 < 0.05
cTn-T, the cardiac troponin T; MDA, malondialdebhyde; MPO, myeloperoxidase; SOD, superoxide dismutase.
*p < 0.05 (compared with Groups B, C and D), p < 0.01 (compared with Groups A, C and D), p < 0.05 (compared with Group D).
Data presented are mean ± SE.Hakan Ceyran, et al.
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was examined using both biochemical and mor-
phologic measurements
22-25 The authors reported
that exogenously administered melatonin effec-
tively protected the liver, lungs, intestines and
brain against oxidative damage. This protection
was evident by reduced lipid peroxidation,
lowered polymorphonuclear leukocyte infiltration,
and reduced antioxidant enzymes.
The observation by Szarszoi et al. that the
exogenous administration of a low physiological
dose of melatonin does not provide protection
does not automatically imply that melatonin is
inactive at physiological concentrations.
20
In our study, we demonstrated that high doses
of melatonin have statistically significant effects
on ischemia-reperfusion-induced myocardial injury
in rat hearts. The levels of cardiac troponin T and
MDA, MPO, and SOD activity in the non-treated
I/R groups were higher than in those treated with
high doses of melatonin. In the melatonin-treated
groups both before ischemia and reperfusion,
these values were significantly lower than in the
non-treated group. These values were slightly
lower in Group C, in which melatonin was given
before ischemia, when compared to Group D, in
which melatonin was administered before reper-
fusion. The effects of melatonin on the expression
of Fas and Bcl-2 in the myocardium were deter-
mined based on the established death-promoting
effect of Fas and the anti-apoptotic effect of Bcl-2.
The high intensity of Bcl-2 in the melatonin
treatment groups (particularly before ischemia)
indicated that anti-apoptotic activity was present.
All these biochemical results were supported
by immunohistochemical and histopathological
findings.
Although low-dose melatonin studies seem to
have been inconclusive, our study has em-
phasized that high-dose melatonin treatment
increases antioxidant enzymes and anti-apoptotic
activity. In conclusion, our study confirmed that
high-dose melatonin treatment acts as a protective
agent against cardiac I/R in rats.
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